Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Bours

Showing results (31-40 of 199) with videos related to

Pageof 20
Sort By:
BMC Cancer|February 2, 2006
A phase 1-2, prospective, double blind, randomized study of the safety and efficacy of Sulfasalazine for the treatment of progressing malignant gliomas: study protocol of [ISRCTN45828668]Pierre A Robe, Didier Martin, Adelin Albert, et al.
Journal of Tropical Pediatrics|May 24, 2008
Spinocerebellar ataxia type 2 (SCA2): clinical features and genetic analysisLéon Mutesa, Geneviève Pierquin, Karin Segers, et al.
Journal of Cellular Physiology|August 1, 2014
Neoadjuvant Chemotherapy in Breast Cancer Patients Induces miR-34a and miR-122 ExpressionPierre Frères, Claire Josse, Nicolas Bovy, et al.
Journal of Tropical Pediatrics|July 10, 2007
Molecular analysis in two siblings African patients with severe form of Hunter Syndrome: identification of a novel (p.Y54X) nonsense mutationLéon Mutesa, Narcisse Muganga, Willy Lissens, et al.
Cancer Genetics and Cytogenetics|March 11, 2008
Germline PTPN11 missense mutation in a case of Noonan syndrome associated with mediastinal and retroperitoneal neuroblastic tumorsLéon Mutesa, Geneviève Pierquin, Nicolas Janin, et al.
BMC Cancer|April 5, 2005
Dexamethasone inhibits the HSV-tk/ ganciclovir bystander effect in malignant glioma cellsPierre A Robe, Minh Nguyen-Khac, Olivier Jolois, et al.
Biomedicines|September 28, 2021
Immunity and Breast Cancer: Focus on EosinophilsAurélie Poncin, Concetta Elisa Onesti, Claire Josse, et al.
Expert Review of Endocrinology & Metabolism|October 7, 2018
Genetic susceptibility in pituitary adenomas: from pathogenesis to clinical implicationsMarie-Lise Jaffrain-Rea, Adrian F Daly, Mariolina Angelini, et al.
BMC Cancer|April 17, 2015
BRCA1 germline mutation and glioblastoma development: report of casesMeriem Boukerroucha, Claire Josse, Karin Segers, et al.
Biochemical Pharmacology|March 8, 2005
Sodium nitroprusside-induced osteoblast apoptosis is mediated by long chain ceramide and is decreased by raloxifeneSabine Olivier, Marianne Fillet, Michel Malaise, et al.
Pageof 20

Showing results (31-40 of 199) with videos related to

Sort By:
Pageof 20
BMC Cancer|February 2, 2006
A phase 1-2, prospective, double blind, randomized study of the safety and efficacy of Sulfasalazine for the treatment of progressing malignant gliomas: study protocol of [ISRCTN45828668]Pierre A Robe, Didier Martin, Adelin Albert, et al.
Journal of Tropical Pediatrics|May 24, 2008
Spinocerebellar ataxia type 2 (SCA2): clinical features and genetic analysisLéon Mutesa, Geneviève Pierquin, Karin Segers, et al.
Journal of Cellular Physiology|August 1, 2014
Neoadjuvant Chemotherapy in Breast Cancer Patients Induces miR-34a and miR-122 ExpressionPierre Frères, Claire Josse, Nicolas Bovy, et al.
Journal of Tropical Pediatrics|July 10, 2007
Molecular analysis in two siblings African patients with severe form of Hunter Syndrome: identification of a novel (p.Y54X) nonsense mutationLéon Mutesa, Narcisse Muganga, Willy Lissens, et al.
Cancer Genetics and Cytogenetics|March 11, 2008
Germline PTPN11 missense mutation in a case of Noonan syndrome associated with mediastinal and retroperitoneal neuroblastic tumorsLéon Mutesa, Geneviève Pierquin, Nicolas Janin, et al.
BMC Cancer|April 5, 2005
Dexamethasone inhibits the HSV-tk/ ganciclovir bystander effect in malignant glioma cellsPierre A Robe, Minh Nguyen-Khac, Olivier Jolois, et al.
Biomedicines|September 28, 2021
Immunity and Breast Cancer: Focus on EosinophilsAurélie Poncin, Concetta Elisa Onesti, Claire Josse, et al.
Expert Review of Endocrinology & Metabolism|October 7, 2018
Genetic susceptibility in pituitary adenomas: from pathogenesis to clinical implicationsMarie-Lise Jaffrain-Rea, Adrian F Daly, Mariolina Angelini, et al.
BMC Cancer|April 17, 2015
BRCA1 germline mutation and glioblastoma development: report of casesMeriem Boukerroucha, Claire Josse, Karin Segers, et al.
Biochemical Pharmacology|March 8, 2005
Sodium nitroprusside-induced osteoblast apoptosis is mediated by long chain ceramide and is decreased by raloxifeneSabine Olivier, Marianne Fillet, Michel Malaise, et al.
Pageof 20